Pediatric adenovirus pneumonia: clinical practice and current treatment

Jie Zhang1, Yiting Zhu1, Yiyang Zhou1

  • 1Department of Pediatrics, The Second School of Medicine, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Frontiers in Medicine
|July 21, 2023
PubMed

Insights

Severe pediatric adenovirus pneumonia, a common respiratory infection, has high mortality and sequelae. Early recognition and management are crucial, as viral load impacts prognosis.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Virology

Background:

  • Adenovirus pneumonia is a frequent pediatric upper respiratory tract infection with a high risk of severe outcomes and mortality.
  • Adenoviruses cause direct cellular damage and trigger immune responses, complicating the infection.
  • Current treatments lack specificity, necessitating supportive care and management of complications.

Purpose of the Study:

  • To review the pathogenesis, early recognition, and therapeutic strategies for severe pediatric adenovirus pneumonia.
  • To identify risk factors associated with poor outcomes, including post-infectious bronchiolitis obliterans (PIBO) and death.
  • To highlight the significance of viral load and serological identification in assessing severity and prognosis.

Main Methods:

  • Review of current literature on adenovirus pneumonia in children.
  • Analysis of clinical symptoms, laboratory tests, and imaging findings for early recognition.
  • Evaluation of treatment modalities including antiviral drugs, respiratory support, and immunomodulatory therapy.
  • Identification of risk factors for severe disease, PIBO, and mortality.

Main Results:

  • Early recognition involves specific symptoms (dyspnea, toxic symptoms), CT findings (atelectasis), and elevated inflammatory markers (CRP, PCT) in young children.
  • Key complications include PIBO and hemophagocytic syndrome; risk factors for PIBO include mechanical ventilation, steroid use, fever duration, and male gender.
  • Factors associated with mortality include hypoxemia, hypercapnia, mechanical ventilation, and low albumin levels.
  • Viral load and serological identification are critical for diagnosis and prognosis.

Conclusions:

  • Effective management of severe pediatric adenovirus pneumonia requires prompt recognition and supportive care.
  • Identifying and mitigating risk factors for PIBO and mortality is essential for improving patient outcomes.
  • Viral load serves as a crucial indicator for disease severity and prognosis in adenovirus pneumonia.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
271
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
165
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
274
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
348